At a glance
- Originator Amorepacific
- Class Dioxolanes; Pyrans
- Mechanism of Action Retinoic acid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Photodamage
Most Recent Events
- 27 May 2004 Clinical trials in Photodamage in South Korea (Topical)